RHRichard Harvey

Richard Harvey

*This is an algorithmically generated author record based on publicly available information.

Richard Harvey has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Another 20th century epidemic

    by Richard Harvey

  • Open Access

    Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations – the Bristol Helicobacter Project

    by R. F. Harvey, J. A. Lane, P. Nair, M. Egger, I. Harvey, J. Donovan, L. Murray

    Aliment Pharmacol Ther 2010; 32: 394–400Summary: Background  Chronic infection of the stomach with Helicobacter pylori is widespread throughout the world and is the major cause of peptic ulcer disease and gastric cancer. Short‐term benefit results from community programmes to eradicate the infection, but there is little information on cumulative long‐term benefit.Aim  To determine whether a community programme of screening for and eradication of H. pylori infection produces further benefit after an initial 2‐year period, as judged by a reduction in GP consultations for dyspepsia.Methods  A total of 1517 people aged 20–59 years, who were registered with seven general practices in Frenchay Health District, Bristol, had a positive 13C‐urea breath test for H. pylori infection and were entered into a randomized double‐blind trial of H. pylori eradication therapy. After 2 years, we found a 35% reduction in GP consultations for dyspepsia (previously reported). In this extension to the study, we analysed dyspepsia consultations between two and 7 years after treatment.Results  Between two and 7 years after treatment, 81/764 (10.6%) of participants randomized to receive active treatment consulted for dyspepsia, compared with 106/753 (14.1%) of those who received placebo, a 25% reduction, odds ratio 0.84 (0.71, 1.00), P = 0.042.Conclusions  Eradication of H. pylori infection in the community gives cumulative long‐term benefit, with a continued reduction in the development of dyspepsia severe enough to require a consultation with a general practitioner up to at least 7 years. The cost savings resulting from this aspect of a community H. pylori eradication programme, in addition to the other theoretical benefits, make such programmes worthy of serious consideration, particularly in populations with a high prevalence of H. pylori infection.


  • Open Access

    Inverse association between gastroesophageal reflux and blood pressure: Results of a large community based study

    by Liam J Murray, Peter McCarron, Roger B McCorry, Lesley A Anderson, Athene J Lane, Brian T Johnston, George Davey Smith, Richard F Harvey

    Background In a cross-sectional community based study, as part of a randomised controlled trial of eradication of Helicobacter pylori infection, the association between blood pressure and symptoms of gastro-oesophageal reflux was examined. Methods Linear regression was used to examine the association between systolic and diastolic blood pressure and the frequency of heartburn and acid regurgitation in 4,902 of 10,537 participants aged 20–59 years. Results In multivariable analyses, adjusted mean systolic blood pressure was 4.2 (95% confidence interval 1.5 to 7.0) mm Hg lower in participants with daily acid regurgitation compared to those with less frequent symptoms. Similarly, for diastolic blood pressure, a reduction of 2.1 (0.0 to 4.3) mm Hg wasobserved. Conclusion People who experience daily symptoms of gastro-oesophageal reflux have lower blood pressure than people with less frequent or no symptoms. It is possible that factors influencing nitric oxide concentrations both at the lower oesophageal sphincter and within the vasculature may be involved. This hypothesis requires confirmation. Trials registration number ISRCTN44816925


  • Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project

    by Richard F Harvey, J Athene Lane, Liam J Murray, Ian M Harvey, Jenny L Donovan, Prakash Nair

    To investigate the effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux. Cross sectional study, followed by a randomised placebo controlled trial. Seven general practices in Bristol, England. 10,537 people, aged 20-59 years, with and without H pylori infection (determined by the (13)C-urea breath test). Prevalence of heartburn and gastro-oesophageal acid reflux at baseline and two years after treatment to eradicate H pylori infection. At baseline, H pylori infection was associated with increased prevalence of heartburn (odds ratio 1.14, 95% confidence interval 1.05 to 1.23) but not reflux (1.05, 0.97 to 1.14). In participants with H pylori infection, active treatment had no effect on the overall prevalence of heartburn (0.99, 0.88 to 1.12) or reflux (1.04, 0.91 to 1.19) and did not improve pre-existing symptoms of heartburn or reflux. H pylori infection is associated with a slightly increased prevalence of heartburn but not reflux. Treatment to eradicate H pylori has no net benefit in patients with heartburn or gastro-oesophageal reflux.


  • Open Access

    Relationship between the birth cohort pattern of Helicobacter pylori infection and the epidemiology of duodenal ulcer

    by R.F. Harvey, R.W. Spence, J.A. Lane, P. Nair, L.J. Murray, J. Donovan

    Background: Helicobacter‐pylori‐related duodenal ulcer (DU) is an important cause of dyspepsia. Aim: To determine the relationship between the pattern of H. pylori infection and the epidemiology of duodenal ulcer in a single population. Design: Prospective two‐part study of (i) patients with DU referred for endoscopy because of dyspepsia, and (ii) the incidence of H. pylori infection in the general population of the same area. Methods: Details of 533 DU patients were recorded, and related to the pattern of H. pylori infection among 10 537 adults in the same community, determined by the 13C‐urea breath test. Results: In patients with DU, birth year was more important than age in determining the rate of presentation for endoscopy (the ‘birth cohort’ effect). H. pylori infection showed a similar birth cohort effect, and the prevalence decreased steadily in those born in successive years, from 28.8% in the 1930s to 3.5% in the 1970s. The proportion of dyspeptic patients who had duodenal ulcers also fell progressively, from 22.2% in 1979 to 5.7% in 1998. H. pylori prevalence and duodenal ulcer incidence were closely correlated at all ages. Discussion: Duodenal ulcer prevalence (as judged by the rate of referral of duodenal ulcer patients for endoscopy) is determined principally by the distribution of H. pylori infection in the local population. The birth cohort effect seen in adult duodenal ulcer patients reflects the acquisition of H. pylori in childhood. In Bristol, H. pylori prevalence and duodenal ulcer incidence are both declining to very low levels.


  • Effect of Helicobacter pylori infection on blood pressure: a community based cross sectional study

    by Richard Harvey, Athene Lane, Liam Murray, Ian Harvey, Prakash Nair, Jenny Donovan